Clinical Trials
4 trialsNCT03784014 2026-04-29
MULTISARC
Institut National de la Santé Et de la Recherche Médicale, France
Phase 3 Completed
NCT05110196 2026-04-07
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Phase 4 Completed
NCT04677595 2026-03-31
GeoMETry-C
Novartis
Phase 2 Completed
NCT04575025 2025-09-15
Special Drug Use-results Surveillance of Tabrecta Tablets
Novartis
Completed